HKEX Disclosure Requirements for an Applicant's Future Plans and Use of Proceeds

The HKEX’s Listing Committee has, since early 2025, intensified its scrutiny of the “Future Plans and Use of Proceeds” (FPUP) section in prospectuses, particularly for applicants on the Main Board and GEM. This shift is driven by a notable uptick in post-listing deviations from stated use of proceeds, which in 2024 triggered 17 separate enforcement actions under the Listing Rules, a 40% increase year-on-year. For CFOs and sponsors preparing an IPO application, the FPUP section is no longer a perfunctory disclosure; it is now a binding commitment that the Exchange will actively monitor against actual deployment. HKEX Listing Decision HKEX-LD132-2024, published in December 2024, explicitly warned that vague or boilerplate language will result in additional vetting rounds, delaying the listing timetable. This article dissects the specific rule requirements, the evolving enforcement landscape, and the practical steps applicants must take to ensure their FPUP disclosures withstand regulatory scrutiny.

The Regulatory Framework: From General Principle to Specific Mandate

Rule 11.07 and the Requirement for a “Clear and Meaningful” Plan

HKEX Main Board Listing Rule 11.07 requires every listing document to include a statement of the applicant’s business objectives and an explanation of how the proceeds from the listing will be used to achieve those objectives. The rule, as amended in the 2024 Listing Rule amendments (effective 1 January 2025), now mandates that the FPUP section must be “clear, specific, and capable of being measured against actual performance.” This is a material departure from the prior standard, which permitted more generic descriptions. For GEM applicants, Rule 11.07A imposes an identical standard, with the additional requirement that the plan must be updated in annual reports for at least three full financial years post-listing.

The HKEX has provided detailed guidance in Listing Decision HKEX-LD132-2024, which examined a hypothetical applicant in the healthcare sector. The decision stated that a plan to use proceeds “for research and development” is insufficient. The applicant must specify the exact projects, the expected timeline for each phase, the targeted therapeutic areas, and the milestones that will trigger the next tranche of funding. The decision noted that the Exchange will cross-reference the FPUP with the applicant’s business plan, which must be filed as part of the A1 application. Any inconsistency between the two documents will result in a deficiency letter under Rule 9.11(3).

The Sponsor’s Due Diligence Obligations Under the SFC Code of Conduct

The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the “SFC Code”), paragraph 17.6, imposes a direct obligation on the sponsor to ensure that the FPUP section is based on reasonable assumptions and is not misleading. The 2024 SFC Enforcement Report, published in March 2025, highlighted two enforcement actions where sponsors were fined a combined HKD 8.4 million for failing to verify the feasibility of the applicant’s stated future plans. In both cases, the sponsor had accepted management’s oral representations without independent verification of the underlying contracts or market data.

Practically, this means the sponsor’s due diligence team must obtain written evidence for each material component of the FPUP. For example, if an applicant states it will use HKD 50 million to build a new production line, the sponsor must obtain the signed equipment purchase agreement, the factory lease, and the environmental impact assessment approval. The SFC’s “Sponsor’s Guide to Due Diligence” (October 2024 edition) explicitly lists the FPUP as a “high-risk area” requiring the same level of scrutiny as financial forecasts.

The Anatomy of a Compliant FPUP Section

Structuring the Use of Proceeds Table: Precision in Allocation and Timing

The FPUP section must include a detailed allocation table, broken down by specific use category, with exact amounts in HKD (or the listing currency). The HKEX’s “Guide for Listing Applicants” (January 2025) provides a template that requires the following columns: (i) use of proceeds category, (ii) amount allocated (in HKD), (iii) percentage of total net proceeds, (iv) expected timeframe for deployment (by financial year), and (v) key milestones or conditions precedent for deployment.

For instance, a technology applicant raising HKD 300 million net proceeds must not state “HKD 100 million for product development.” Instead, the table should show: “HKD 100 million (33.3%) for development of the Gen-3 cloud platform, with HKD 40 million allocated to engineering headcount in FY2025, HKD 35 million to cloud infrastructure contracts signed with AWS (contract reference AWS-2024-0456), and HKD 25 million to third-party testing and certification by TÜV Rheinland, all to be deployed within 18 months of listing.” The Exchange has confirmed that it will accept a deployment window of up to 36 months for large-scale capital expenditure, but any extension requires a shareholder vote under Rule 14.34.

Linking Future Plans to Business Strategy: The “Coherence” Test

The FPUP must be internally consistent with the applicant’s business strategy section and the risk factors. The HKEX’s 2024 review of 120 prospectuses found that 22% contained a mismatch between the stated future plans and the risk factors. For example, one applicant stated it would use 60% of proceeds to expand into Southeast Asia, yet the risk factors only discussed risks in the PRC market. The Exchange issued a deficiency letter requiring the applicant to either add the relevant risk factors or revise the FPUP to reflect the actual strategy.

The coherence test extends to the applicant’s track record. If the applicant has no experience in a new business line it proposes to fund, the FPUP must disclose this and explain how it will acquire the necessary expertise, including the identity of any key hires or joint venture partners. Listing Decision HKEX-LD132-2024 specifically stated that “a plan to hire a team post-listing is not a sufficient answer; the applicant must demonstrate that it has already identified and entered into binding agreements with the key personnel or partners.”

Enforcement and Post-Listing Compliance: The New Normal

Monitoring Through Annual Reports and the “Use of Proceeds” Statement

Rule 13.47 requires every listed issuer to include in its annual report a statement comparing the actual use of proceeds against the stated FPUP. The 2025 amendments to this rule now require the statement to be in a prescribed format, with a reconciliation table showing any material deviation. A deviation is deemed material if it exceeds 20% of the allocated amount for any single category or if it results in a change in the overall business strategy.

The HKEX’s Enforcement Division has established a dedicated team to review these statements. In the first quarter of 2025, the team issued 14 letters of inquiry to issuers whose actual deployment lagged significantly behind the stated timeline. In three cases, the Exchange suspended trading under Rule 6.01(3) pending a detailed explanation. For GEM issuers, the requirement is even more stringent: Rule 18.07 requires a quarterly update on the use of proceeds for the first two years post-listing, filed via the HKEX’s e-Submission System within 14 business days of each quarter-end.

Consequences of Non-Compliance: From Fines to Delisting

The SFC and HKEX have a range of enforcement tools. For material misstatements in the FPUP at the time of listing, the SFC can bring proceedings under section 298 of the Securities and Futures Ordinance (Cap. 571) for making false or misleading statements in a prospectus. The maximum penalty is a fine of HKD 1 million and imprisonment for 10 years. In practice, the SFC has preferred to impose fines on the issuer and its directors, with the largest sanction to date being HKD 15 million levied against a Main Board issuer in 2024 for a FPUP that was found to be “entirely aspirational and lacking any reasonable basis.”

For post-listing deviations, the HKEX can issue a public censure, impose a fine of up to HKD 10 million under Rule 2A.10, or refer the matter to the Listing Committee for a potential delisting under Rule 6.10. The Exchange’s 2024 Annual Enforcement Report noted that 8 issuers were referred for delisting proceedings specifically due to repeated failures to deploy proceeds as stated, with one case involving a company that had held 95% of its IPO proceeds in cash for over four years without any meaningful deployment.

Practical Considerations for Cross-Border Structures

The VIE and PRC Issuer Conundrum

For PRC-based applicants using a VIE structure or a Cayman-incorporated holding company, the FPUP must address the repatriation of funds. The HKEX’s “Guidance Letter on VIE Structures” (GL94-19, updated March 2025) requires the FPUP to explicitly state the mechanism for transferring proceeds from the Hong Kong listing vehicle to the PRC operating entity. This includes the specific PRC regulatory approvals required, such as SAFE registration, NDRC filing, or MOFCOM clearance, and the estimated timeline for each step.

A common deficiency is the failure to account for PRC foreign exchange controls. In Listing Decision HKEX-LD135-2025, the Exchange rejected an FPUP that proposed to transfer HKD 200 million to a PRC subsidiary without any mention of the State Administration of Foreign Exchange (SAFE) circular 37 requirements. The applicant was required to resubmit with a detailed repatriation plan, including a legal opinion from a qualified PRC law firm confirming the feasibility of the proposed structure.

The Impact of the 2025 HKMA Circular on Capital Flow Monitoring

The Hong Kong Monetary Authority (HKMA) issued a circular in February 2025 (HKMA Circular B10/1C) requiring all authorized institutions to report any use of IPO proceeds that involves a cross-border transfer exceeding HKD 50 million. While this circular is primarily directed at banks, it has a direct impact on the FPUP because the HKEX now expects applicants to disclose that such reporting will occur. The FPUP must therefore include a statement acknowledging the HKMA’s monitoring framework and confirming that the issuer will cooperate with its sponsoring bank to ensure compliance.

For family offices and institutional investors, this means that the FPUP is now a document that will be cross-referenced by multiple regulators. Any inconsistency between the FPUP, the bank’s compliance records, and the annual report will trigger a cascade of inquiries. The practical takeaway is that the FPUP must be drafted with the same precision as a financial model, with each line item backed by a verifiable source.

Actionable Takeaways

• Precision in allocation is non-negotiable: Every use of proceeds category must specify exact amounts, deployment timelines, and contractual milestones, with deviations exceeding 20% triggering mandatory shareholder approval under Rule 14.34.
• The sponsor must independently verify each FPUP component: The SFC Code paragraph 17.6 requires written evidence for every material assumption, and oral representations from management are no longer acceptable.
• Cross-border repatriation plans must be legally grounded: For VIE or PRC issuers, the FPUP must include a detailed regulatory pathway under SAFE, NDRC, and MOFCOM rules, supported by a PRC legal opinion.
• Post-listing compliance is a continuous obligation: Annual reports under Rule 13.47 and GEM quarterly updates under Rule 18.07 must reconcile actual deployment against the FPUP, with the HKEX Enforcement Division actively monitoring for deviations.
• The FPUP is a binding commitment, not a forecast: Any material misstatement at listing can result in SFC prosecution under section 298 of the SFO, with penalties including fines of up to HKD 1 million and imprisonment for 10 years.